Audit Integrity and Zach's downgrade Synageva and Morgan Stanley Upgrades and sets a juicy target.Are Audit and Zach's trying to get some special customers in and Morgan some out? Time will tell. The Fool does not like Synageva.
Motley fool is for fools.Once a cute start up,they were bought up and now spew garbage,and collect a fee in return Ignore them
They are like any investment counselor, paid or free, Cramer, GS, etc. You have to weigh WHAT the say and WHY against your own experience and common sense.So based on that the long term prospects for Syngeva just don't look positive to me. Limited pipeline and patient base. Management that might be motivated to just milk the Trimeris cash.You? Why?